These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24032256)

  • 1. In patients with chronic diabetic nephropathy, do angiotensin-converting enzyme inhibitors (ACEI) have greater renal protective effect as compared to angiotensin receptor blockers (ARB)?
    Tucker S; Chen Y; Abell R
    J Okla State Med Assoc; 2013 Jul; 106(7):294-5. PubMed ID: 24032256
    [No Abstract]   [Full Text] [Related]  

  • 2. Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria.
    Hsu FY; Lin FJ; Ou HT; Huang SH; Wang CC
    Kidney Blood Press Res; 2017; 42(2):358-368. PubMed ID: 28618426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial nitric oxide synthase gene polymorphisms and renal responsiveness to RAS inhibition therapy in type 2 diabetic Asian Indians.
    Cheema BS; Kohli HS; Sharma R; Bhansali A; Khullar M
    Diabetes Res Clin Pract; 2013 Mar; 99(3):335-42. PubMed ID: 23260854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic resistance to ACEI and ARB combination in macroalbuminuric diabetic nephropathy.
    Futrakul N; Futrakul P
    Clin Nephrol; 2012 Sep; 78(3):250. PubMed ID: 22541688
    [No Abstract]   [Full Text] [Related]  

  • 5. Meta-analysis: the efficacy and safety of combined treatment with ARB and ACEI on diabetic nephropathy.
    Ren F; Tang L; Cai Y; Yuan X; Huang W; Luo L; Zhou J; Zheng Y
    Ren Fail; 2015 May; 37(4):548-61. PubMed ID: 25707526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE inhibitors or ARBs for diabetic nephropathy: the unrelenting debate.
    Kota SK; Meher LK; Jammula S; Kota SK; Modi KD
    Diabetes Metab Syndr; 2012; 6(4):215-7. PubMed ID: 23199543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of renin-angiotensin system blockers on renal and cardiovascular outcomes in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials.
    Liu X; Ma L; Li Z
    J Endocrinol Invest; 2020 Jul; 43(7):959-972. PubMed ID: 31939197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of angiotensin-converting enzyme inhibitors in patients with diabetic nephropathy.
    How HY; Sibai BM
    J Matern Fetal Neonatal Med; 2002 Dec; 12(6):402-7. PubMed ID: 12683651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Ophiocordyceps sinensis (syn. Cordyceps sinensis) combined with angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) versus ACEI/ARB alone in the treatment of diabetic kidney disease: a meta-analysis.
    Luo Y; Yang SK; Zhou X; Wang M; Tang D; Liu FY; Sun L; Xiao L
    Ren Fail; 2015 May; 37(4):614-34. PubMed ID: 25682973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis.
    Jennings DL; Kalus JS; Coleman CI; Manierski C; Yee J
    Diabet Med; 2007 May; 24(5):486-93. PubMed ID: 17367311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of angiotensin receptor blockers in diabetic nephropathy.
    Sharma AM; Weir MR
    Postgrad Med; 2011 May; 123(3):109-21. PubMed ID: 21566421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
    Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal Protective Effects of Combination of Diltiazem and ACEI/ARB on the Progression of Diabetic Nephropathy: Randomized Controlled Trial.
    Krairittichai U; Sarinnapakorn V; Mahannopkul R; Ainwan P
    J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S40-7. PubMed ID: 29927180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of RAAS inhibition in diabetic nephropathy].
    Tsuruya K; Toyonaga J
    Nihon Rinsho; 2012 Jul; 70 Suppl 5():411-8. PubMed ID: 23156430
    [No Abstract]   [Full Text] [Related]  

  • 15. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
    St Peter WL; Odum LE; Whaley-Connell AT
    Pharmacotherapy; 2013 May; 33(5):496-514. PubMed ID: 23576066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mineralocorticoid receptor antagonists on the progression of diabetic nephropathy.
    Sun LJ; Sun YN; Shan JP; Jiang GR
    J Diabetes Investig; 2017 Jul; 8(4):609-618. PubMed ID: 28107779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of ACEI versus ARB in managing hypertensive overt diabetic nephropathy: long-term analysis.
    Ozturk S; Sar F; Bengi-Bozkurt O; Kazancioglu R
    Kidney Blood Press Res; 2009; 32(4):268-75. PubMed ID: 19776644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination Therapy with Chinese Medicine and ACEI/ARB for the Management of Diabetic Nephropathy: The Promise in Research Fragments.
    Tu X; Ye X; Xie C; Chen J; Wang F; Zhong S
    Curr Vasc Pharmacol; 2015; 13(4):526-39. PubMed ID: 25360835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renoprotective effect of triple therapy with low-dose angiotensin receptor blocker, low-dose diuretic and Ca-antagonist in hypertensive type 2 diabetic patients with overt nephropathy].
    Kuriyama S; Tomonari H; Ohtsuka Y; Ohkido I; Hosoya T
    Nihon Jinzo Gakkai Shi; 2003; 45(4):367-71. PubMed ID: 12806973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Meta analysis of the efficacy and safety of combined treatment with ARB and ACEI on diabetic kidney disease].
    Gu J; Han L; Liu Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jun; 38(6):623-30. PubMed ID: 23828705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.